Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary AldosteronismNot Yet Recruiting
Sponsor: Queen Mary University of London
Primary Aldosteronism
United Kingdom
Sponsor: University of Cincinnati
Recurrent Head and Neck Cancer · Head and Neck Cancer · Head and Neck Neoplasms · Metastatic Cancer
United States
Sponsor: AstraZeneca
Sepsis · Acute Kidney Injury
United States, Argentina, Belgium, Canada, Czechia +9 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus · Type 2 Diabetes With Chronic Kidney Disease
United States, Bulgaria, China, Denmark, Germany +11 more
- Saracatinib Trial TO Prevent FOPActive Not Recruiting
Sponsor: Amsterdam UMC, location VUmc
Fibrodysplasia Ossificans Progressiva
Germany, Netherlands, United Kingdom
Sponsor: AstraZeneca
Advanced Solid Tumors
United States, South Korea, Spain, United Kingdom
Sponsor: AstraZeneca
Cardiovascular Diseases
China
Sponsor: AstraZeneca
Liver Fibrosis · Hepatic Cirrhosis
United States
- INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World UseRecruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus (SLE)
Argentina, China, Costa Rica, Egypt, Guatemala +7 more
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
United States, Australia, Brazil, Canada, Denmark +12 more
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
China
Sponsor: AstraZeneca
Mantle-cell Lymphoma
Spain
- A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With DyslipidaemiaActive Not Recruiting
Sponsor: AstraZeneca
Dyslipidaemia
Russia
Sponsor: AstraZeneca
Chronic Kidney Disease and Hypertension
United States, Argentina, Bulgaria, Canada, Taiwan +4 more
Sponsor: AstraZeneca
Relapsed Refractory Multiple Myeloma
United States, Australia, Brazil, Canada, China +10 more
- A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)Active Not Recruiting
Sponsor: AstraZeneca
RSV Respiratory Syncytial Virus
United States
Sponsor: American Society of Clinical Oncology
Lymphoma, Non-Hodgkin · Multiple Myeloma · Advanced Solid Tumors
United States, Puerto Rico
Sponsor: AstraZeneca
Hepatic Impairment
United States
- Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma DiagnosisRecruiting
Sponsor: AstraZeneca
Suspected Asthma
China
- Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLCActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Lung Cancer Metastatic
Australia, Canada
- First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Active Not Recruiting
Sponsor: Daiichi Sankyo Co., Ltd.
Hormone Receptor Positive Breast Cancer · Triple Negative Breast Cancer · Non-small Cell Lung Cancer
United States, Japan
Sponsor: AstraZeneca
Lung Cancer
Brazil
Sponsor: AstraZeneca
Non-small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma · Colorectal Carcinoma · Pancreatic Adenocarcinoma
United States
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Brazil, China, Czechia +18 more
Sponsor: AstraZeneca
Rate of CKD Diagnosis in Patients With AH and CKD Markers · Demographic and Clinical Characteristics for Those Patients · Routine Therapy Before and After the Diagnosis of CKD
Kazakhstan